TAYLOR KASPER: Open Payments
NPI 1124547971 · LEXINGTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 13 payments from 8 companies in 2025. Trend: 2023 $100 · 2024 $204 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Novo Nordisk Inc | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: MOUNJARO, AIRSUPRA, Wegovy, Qelbree, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, GVOKE HYPOPEN, REPATHA.
Industry payments across MI — which companies pay providers there.
